Richard Finn

机构：University of California, Los Angeles, UCLA Health · ORCID：0000-0003-2494-2126

发表论文 11 篇 · 总被引 440 次 · h-index 4

代表论文

• The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells (1997 · Oncogene · 被引 334)
• Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study (2025 · The Lancet Oncology · 被引 67)
• Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma (2020 · Saudi Journal of Gastroenterology · 被引 25)
• Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma (2025 · Journal of Hepatology · 被引 11)
• Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States (2025 · Journal of Hepatocellular Carcinoma · 被引 1)
• The Dominicans in the British Isles and Beyond (2023 · Cambridge University Press eBooks · 被引 1)